Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Drug Discovery Today
|
July 25, 2024
Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world
Charles H Jones, Subha Madhavan, Kannan Natarajan, et al.
NPJ Vaccines
|
February 9, 2024
Exploring the future adult vaccine landscape-crowded schedules and new dynamics
Charles H Jones, Matthew P Jenkins, B Adam Williams, et al.
Blood
|
July 2, 2002
Analysis of the hematopoietic potential of muscle-derived cells in mice
Hartmut Geiger, Jarrod M True, Barry Grimes, et al.
Iscience
|
March 24, 2025
Stakeholder perspective and sentiment in a rapidly growing United States adult vaccination environment
Anthony Hill, Ryan Arvin, Marie Beitelshees, et al.
Iscience
|
September 15, 2025
Stakeholder readiness in the evolving adult vaccine market
Matthew P Jenkins, Anthony Hill, Antonietta F Forte, et al.
PNAS Nexus
|
December 20, 2024
In silico prediction of pathogen's pandemic potential using the viral trait assessment for pandemics (ViTAP) model
Charles H Jones, Marie Beitelshees, B Adam Williams, et al.
Journal of Athletic Training
|
April 11, 2012
Limb blood flow after class 4 laser therapy
Kelly A Larkin, Jeffrey S Martin, Elizabeth H Zeanah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 19, 2025
Framework to identify innovative sources of value creation from platform technologies
Charles H Jones, Marie Beitelshees, Andrew Hill, et al.
Vaccines
|
August 28, 2025
Economic Impacts of Initiating Vaccination at 3 Months vs. 6 Months in an Influenza Pandemic in the United States
Van Hung Nguyen, Pascal Crepey, B Adam Williams, et al.
Drug Discovery Today
|
August 3, 2024
Deciphering immune responses: a comparative analysis of influenza vaccination platforms
Charles H Jones, Teresa Hauguel, Marie Beitelshees, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Drug Discovery Today
|
July 25, 2024
Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world
Charles H Jones, Subha Madhavan, Kannan Natarajan, et al.
NPJ Vaccines
|
February 9, 2024
Exploring the future adult vaccine landscape-crowded schedules and new dynamics
Charles H Jones, Matthew P Jenkins, B Adam Williams, et al.
Blood
|
July 2, 2002
Analysis of the hematopoietic potential of muscle-derived cells in mice
Hartmut Geiger, Jarrod M True, Barry Grimes, et al.
Iscience
|
March 24, 2025
Stakeholder perspective and sentiment in a rapidly growing United States adult vaccination environment
Anthony Hill, Ryan Arvin, Marie Beitelshees, et al.
Iscience
|
September 15, 2025
Stakeholder readiness in the evolving adult vaccine market
Matthew P Jenkins, Anthony Hill, Antonietta F Forte, et al.
PNAS Nexus
|
December 20, 2024
In silico prediction of pathogen's pandemic potential using the viral trait assessment for pandemics (ViTAP) model
Charles H Jones, Marie Beitelshees, B Adam Williams, et al.
Journal of Athletic Training
|
April 11, 2012
Limb blood flow after class 4 laser therapy
Kelly A Larkin, Jeffrey S Martin, Elizabeth H Zeanah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 19, 2025
Framework to identify innovative sources of value creation from platform technologies
Charles H Jones, Marie Beitelshees, Andrew Hill, et al.
Vaccines
|
August 28, 2025
Economic Impacts of Initiating Vaccination at 3 Months vs. 6 Months in an Influenza Pandemic in the United States
Van Hung Nguyen, Pascal Crepey, B Adam Williams, et al.
Drug Discovery Today
|
August 3, 2024
Deciphering immune responses: a comparative analysis of influenza vaccination platforms
Charles H Jones, Teresa Hauguel, Marie Beitelshees, et al.
Page
of 3